Watch TDOC. Know when insiders buy.
One email the day a filing lands. Free.
TDOC
Teladoc Health, Inc.
6.30
+0.09 +1.53%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
33
FLAG · insiders 32, shorts 34
Insiders, 90 days
−$461K
net selling · 0 buys, 9 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.1BP/E —DIV YIELD —FCF YIELD 22.15%REV TTM $2.5B −2.1%NET INCOME −$177.4MNET CASH $731.9M52W 4.47 – 9.72SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $606.9M | −4.0% | — | −$37.1M | −$38.9M | — | -0.21 | $64.7M | $928K | $63.7M | Jul 30 |
| Q1 2026 · Mar 31 | $613.8M | −2.5% | — | −$61.8M | −$63.8M | — | -0.36 | $9.5M | $1.7M | $7.9M | Apr 30 |
| Q4 2025 · Dec 31derived | $642.3M | +0.3% | — | −$36M | −$25.1M | — | -0.14 | $87.7M | $2.6M | $85.1M | Feb 26 |
| Q3 2025 · Sep 30 | $626.4M | −2.2% | — | −$52M | −$49.5M | — | -0.28 | $99.3M | $2.3M | $97M | Oct 30 |
| Q2 2025 · Jun 30 | $631.9M | −1.6% | — | −$54.4M | −$32.7M | — | -0.19 | $91.4M | $1.3M | $90.2M | Jul 30 |
| Q1 2025 · Mar 31 | $629.4M | −2.6% | — | −$120.6M | −$93M | — | -0.53 | $15.9M | $2.7M | $13.2M | Apr 30 |
| Q4 2024 · Dec 31derived | $640.5M | −3.0% | — | −$48.2M | −$48.4M | — | -0.26 | $85.9M | $6.1M | $79.8M | Feb 26 |
| Q3 2024 · Sep 30 | $640.5M | −3.0% | — | −$44.4M | −$33.3M | — | -0.19 | $110.2M | $1.6M | $108.6M | Oct 30 |
| Q2 2024 · Jun 30 | $642.4M | — | — | −$841.1M | −$837.7M | — | -4.92 | $88.7M | $1.9M | $86.8M | Jul 30 |
| Q1 2024 · Mar 31 | $646.1M | — | — | −$87.1M | −$81.9M | — | -0.49 | $8.9M | $1.1M | $7.8M | May 1 |
| Q4 2023 · Dec 31derived | $660.5M | — | — | −$35.1M | −$28.9M | — | -0.17 | $130.1M | $1.4M | $128.7M | Feb 26 |
| Q3 2023 · Sep 30 | $660.2M | — | — | −$64.7M | −$57.1M | — | -0.35 | $105.6M | $5.8M | $99.8M | Oct 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.5B | — | −$263M | −$200.3M | -7.9% | -1.14 | $294.4M | $8.9M | $285.5M | — | — |
| FY2024 · to Dec 31 | $2.6B | — | −$1B | −$1B | -39.0% | -5.87 | $293.7M | $10.8M | $282.9M | — | — |
| FY2023 · to Dec 31 | $2.6B | — | −$248.6M | −$220.4M | -8.5% | -1.34 | $350M | $11.5M | $338.6M | — | — |
| FY2022 · to Dec 31 | $2.4B | 69.1% | −$13.7B | −$13.7B | -567.5% | -84.60 | $189.3M | $16.5M | $172.8M | — | — |
| FY2021 · to Dec 31 | $2B | 68.0% | −$265.6M | −$428.8M | -21.1% | -2.73 | $194M | $8.5M | $185.5M | — | — |
| FY2020 · to Dec 31 | $1.1B | 64.3% | −$506.4M | −$485.1M | -44.3% | -5.36 | −$53.5M | $4M | −$57.5M | — | — |
Every number comes from Teladoc Health, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.